Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125–139. DOI: 10.1056/NEJMoa070716
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367(2):124–134. DOI: 10.1056/NEJMoa1204242. [Erratum. N Engl J Med 2012;367:481].
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367(20): 1901–1911. DOI: 10.1056/NEJMoa1209759
Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013;310(17):1809–1817. DOI: 10.1001/jama.2013.280502
Guidet B, Martinet O, Boulain T, et al. Assessment of haemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012;16(3):R94. DOI: 10.1186/cc11358
James MFM, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011;107(5):693–702. DOI: 10.1093/bja/aer229
Siegemund M. BaSES Trial: Basel Starch Evaluation in Sepsis. ClinicalTrialsgov Identifier: NCT00273728; 2013.
Meybohm P, Van Aken H, Gasperi A, et al. Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients—a multidisciplinary statement. Crit Care 2013;17(4):R166. DOI: 10.1186/cc12845
Lewis SR, Pritchard MW, Evans DJw, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 2018;8(8):CD000567. DOI: 10.1002/14651858.CD000567.pub7